Bioventus Agrees to Nationwide Contract with Cigna Commercial Plans for DUROLANE® and GELSYN-3® for Knee Osteoarthritis
May 02, 2022 07:00 ET
|
Bioventus, Inc.
DURHAM, N.C., May 02, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, has agreed to a nationwide contract...
Bioventus Announces Preliminary First Quarter Net Sales and Adjusted EBITDA
April 26, 2022 09:05 ET
|
Bioventus, Inc.
DURHAM, N.C., April 26, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, announced today preliminary financial...
Bioventus Announces $415 Million Offering of Senior Notes
April 26, 2022 08:38 ET
|
Bioventus, Inc.
DURHAM, N.C., April 26, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, announced today that, subject to...
Bioventus to Report First Quarter of Fiscal Year 2022 Financial Results on May 10, 2022
April 25, 2022 07:00 ET
|
Bioventus, Inc.
DURHAM, N.C., April 25, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will report...
Bioventus TheraSkin Coverage Expands to Provide for 17 Million More Covered Lives
April 08, 2022 09:15 ET
|
Bioventus, Inc.
DURHAM, N.C., April 08, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, announced today that TheraSkin...
Bioventus Announces Inducement Equity to SVP Chief Financial Officer Mark Singleton
April 05, 2022 07:00 ET
|
Bioventus, Inc.
DURHAM, N.C., April 05, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, announced today the issuance on April...
Bioventus Exercises Call Option to Acquire CartiHeal
April 04, 2022 07:00 ET
|
Bioventus, Inc.
DURHAM, N.C., April 04, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it has exercised...
Bioventus to Present at the Canaccord Genuity Musculoskeletal Conference
March 16, 2022 07:00 ET
|
Bioventus, Inc.
DURHAM, N.C., March 16, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Ken Reali, chief executive officer, will...
Bioventus Reports Fourth Quarter and Full Year 2021 Financial Results; Introduces Full Year 2022 Financial Guidance
March 10, 2022 07:00 ET
|
Bioventus, Inc.
DURHAM, N.C., March 10, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) ("Bioventus" or "the Company"), a global leader in innovations for active healing, today reported financial results for...
Bioventus Receives 510(k) Clearance for StimRouter Pain Management Device
March 01, 2022 07:00 ET
|
Bioventus, Inc.
DURHAM, N.C., March 01, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, announced that the US Food and Drug...